ATE268784T1 - Peptidfragment von lalf mit antiviraler wirkung - Google Patents

Peptidfragment von lalf mit antiviraler wirkung

Info

Publication number
ATE268784T1
ATE268784T1 AT98203293T AT98203293T ATE268784T1 AT E268784 T1 ATE268784 T1 AT E268784T1 AT 98203293 T AT98203293 T AT 98203293T AT 98203293 T AT98203293 T AT 98203293T AT E268784 T1 ATE268784 T1 AT E268784T1
Authority
AT
Austria
Prior art keywords
lalf
peptide
hep
induce
effect
Prior art date
Application number
AT98203293T
Other languages
English (en)
Inventor
Vallespi Maribel Guerra
Jesus Arana Rosainz Manuel De
Plaza Ayuntamiento
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Application granted granted Critical
Publication of ATE268784T1 publication Critical patent/ATE268784T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98203293T 1997-09-29 1998-09-29 Peptidfragment von lalf mit antiviraler wirkung ATE268784T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1997106A CU22700A1 (es) 1997-09-29 1997-09-29 Formulación farmacéutica anti-viral que contiene un péptido de la proteína factor anti-lps de limulus y su uso

Publications (1)

Publication Number Publication Date
ATE268784T1 true ATE268784T1 (de) 2004-06-15

Family

ID=5459370

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98203293T ATE268784T1 (de) 1997-09-29 1998-09-29 Peptidfragment von lalf mit antiviraler wirkung

Country Status (10)

Country Link
US (2) US6191114B1 (de)
EP (1) EP0905141B1 (de)
CN (1) CN1218057A (de)
AT (1) ATE268784T1 (de)
CU (1) CU22700A1 (de)
DE (1) DE69824358T2 (de)
DK (1) DK0905141T3 (de)
ES (1) ES2223105T3 (de)
PT (1) PT905141E (de)
SI (1) SI0905141T1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040199099A1 (en) * 1998-07-10 2004-10-07 Matson James R Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US6592869B2 (en) 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
PT1212045T (pt) 1999-08-24 2016-11-22 Abic Biological Laboratories Ltd Composição de vacina e método de utilização da mesma
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
US20060129082A1 (en) * 2002-08-13 2006-06-15 Jacek Rozga Selective plasma exchange therapy
CU23389B6 (es) * 2005-12-29 2009-07-16 Ct Ingenieria Genetica Biotech Combinación farmacéutica citoprotectora, útil en la prevención y tratamiento del síndrome de respuesta inflamatoria sistémica
CU23582A1 (es) 2006-02-24 2010-10-30 Ct Ingenieria Genetica Biotech Péptidos con capacidad anti-tumoral e inmunomoduladora
EP2108372A1 (de) * 2008-04-09 2009-10-14 Forschungszentrum Borstel Leibniz-Zentrum für Medizin und Biowissenschaften Neue antimikrobielle Peptide
CN113563427B (zh) * 2021-06-02 2022-02-01 北京师范大学珠海校区 抗菌短肽lbd-s及其应用和药物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006892A (en) 1991-05-16 1992-12-30 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
US5780429A (en) * 1995-12-22 1998-07-14 Marine Biological Laboratory Anti-LPS factor from horseshoe crabs and methods of use

Also Published As

Publication number Publication date
EP0905141A1 (de) 1999-03-31
PT905141E (pt) 2004-10-29
CU22700A1 (es) 2001-07-31
DK0905141T3 (da) 2004-10-25
DE69824358T2 (de) 2005-06-09
SI0905141T1 (en) 2004-12-31
DE69824358D1 (de) 2004-07-15
US6632793B1 (en) 2003-10-14
CN1218057A (zh) 1999-06-02
ES2223105T3 (es) 2005-02-16
EP0905141B1 (de) 2004-06-09
US6191114B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
ATE268784T1 (de) Peptidfragment von lalf mit antiviraler wirkung
ATE63748T1 (de) Enzymwiderstandsfaehige immunomodulatorische peptide.
LV12038A (lv) Panemieni un lidzekli cilveka seksualas reakcijas modulesanai
MX7531E (es) Proceso biotecnologico para alterar la proliferacion y/o el desarrollo de cultivos tisulares
DE69812941D1 (de) Verwendung von mikropartikeln mit adsorbiertem antigen zur stimulierung der immunabwehr
DE68926859D1 (de) Natürlicher killerzellen-stimulationsfaktor
TR200001228T2 (tr) T yardımcı hücre tür 2 kökenli bağışıklık hastalıklarının retinoit antagonistlerle tedavisi
ATE531382T1 (de) Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen
DK1019073T3 (da) Apoliprotein A-I agonister og deres anvendelse til at behandle dyslipidæmiske lidelser
ATE286510T1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE3582973D1 (de) Neues derivat des humangammainterferon-polypeptids.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
SE8700203L (sv) Pyroglutamidderivat
MX170929B (es) Empleo de substancias antigenicas para la profilaxis o la terapia de transtornos y enfermedades en el conducto digestivo de animales y humanos
KR870004971A (ko) 티아졸론 및 이의 제조방법
DE69106407D1 (de) Verfahren zur Herstellung von rekombinantem menschlichem gamma-Interferon ohne Cystein und ohne Methionin am N-Terminal.
IT1118264B (it) Amminoderivati della pirazolo(1,5-a)s triazina particolarmente utili in terapia e procedimento per la loro preparazione
DE69127975T2 (de) Impfstoffe
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
DE59106997D1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
ES2129047T3 (es) Metodo para mejorar la memoria y la calidad de vida.
DE69003216T2 (de) Verwendung von somatostatin.
IT8920643A0 (it) Impiego della farina di fibra di nocciola in campo dietetico per l'ottenimento di effetti dimagranti e di migliorato assorbimento intestinale degli amminoacidi.
ES290272U (es) Pulsera
IT1229826B (it) Dispositivo per il controllo di lampade di illuminazione, in particolare dispositivo simulatore del ciclo solare per il controllo dell'illuminazione di presepi e/o simili

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0905141

Country of ref document: EP

REN Ceased due to non-payment of the annual fee